176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-13.82%
Cash & equivalents declining -13.82% while MRVL's grows 37.72%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
5.52%
Short-term investments yoy growth 0.5-0.75x MRVL's 9.43%. Martin Whitman would be cautious about lagging liquidity buildup.
-1.91%
Below half of MRVL's 16.55%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
39.23%
Receivables growth above 1.5x MRVL's 2.47%. Michael Burry would check for potential credit bubble or inflated top-line.
-2.21%
Inventory growth below half of MRVL's 0.85%. David Dodd would check if that's due to efficiency or supply constraints.
No Data
No Data available this quarter, please select a different quarter.
6.23%
Below half of MRVL's 13.25%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
5.74%
Below half MRVL's 11.60%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
-3.06%
Above 1.5x MRVL's -1.28%. Michael Burry might suspect inflated intangible valuations or questionable M&A additions.
-3.06%
Above 1.5x MRVL's -1.28%. Michael Burry sees potential overpaying or intangible bubble risk. Check synergy assumptions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
49.63%
Less than half of MRVL's -1.82%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
3.44%
≥ 1.5x MRVL's 0.06%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
5.70%
1.25-1.5x MRVL's 5.12%. Bruce Berkowitz sees a stronger asset build. Check if it's producing returns.
21.36%
Above 1.5x MRVL's 14.21%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
-100.00%
Above 1.5x MRVL's -2.88%. Michael Burry sees a major discrepancy in short-term leverage. Check coverage and liquidity carefully.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.31%
1.25-1.5x MRVL's 9.12%. Martin Whitman is wary of bigger short-term burdens.
-100.00%
Higher Long-Term Debt Growth compared to MRVL's zero value, indicating worse performance.
100.00%
Higher Non-Current Deferred Revenue Growth compared to MRVL's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.17%
Less than half of MRVL's 19.83%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
11.98%
Similar yoy to MRVL's 12.54%. Walter Schloss sees parallel expansions in total liabilities.
0.58%
50-75% of MRVL's 0.89%. Bruce Berkowitz notes minimal new equity relative to competitor.
11.75%
0.5-0.75x MRVL's 16.46%. Martin Whitman is wary of weaker retention or lower profitability.
0.58%
Less than half of MRVL's 8.23%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
3.63%
0.75-0.9x MRVL's 4.23%. Bill Ackman wonders if competitor is growing equity faster.
5.70%
1.25-1.5x MRVL's 5.12%. Bruce Berkowitz checks if expansions are well-justified by ROI.
5.52%
0.5-0.75x MRVL's 9.43%. Martin Whitman sees possible missed opportunities vs. competitor.
-100.00%
Above 1.5x MRVL's -2.88%. Michael Burry sees a major jump. Investigate leverage rationale.
11.11%
Less than half of MRVL's -41.69%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
